Sutent and Psychiatric symptom - a phase IV clinical study of FDA data

Summary:

Psychiatric symptom is reported as a side effect among people who take Sutent (sunitinib malate), especially for people who are male, 50-59 old, also take Plavix, and have Pain.

The phase IV clinical study analyzes which people have Psychiatric symptom when taking Sutent. It is created by eHealthMe based on reports of 44,359 people who have side effects when taking Sutent from the FDA, and is updated regularly.

What is Sutent?

Sutent has active ingredients of sunitinib malate. It is often used in renal cell carcinoma. eHealthMe is studying from 44,554 Sutent users. Check the latest studies of Sutent.

What is Psychiatric symptom?

Psychiatric symptom is found to be associated with 639 drugs and 757 conditions by eHealthMe. Check the latest studies of Psychiatric symptom.

On Aug, 04, 2026

44,359 people reported to have side effects when taking Sutent.
Among them, 16 people (0.04%) have Psychiatric symptom.

Among these 16 people:

What is the gender of people who have Psychiatric symptom when taking Sutent? *

female: 37.5 %
male: 62.5 %

What is the age of people who have Psychiatric symptom when taking Sutent? *

What are other drugs people take besides Sutent? *

What are other side effects people have besides Psychiatric symptom? *

Stress And Anxiety: 10 people, 62.50%
Fatigue (feeling of tiredness): 10 people, 62.50%
Weakness: 9 people, 56.25%
Pain: 9 people, 56.25%
Dehydration (dryness resulting from the removal of water): 9 people, 56.25%
Cardiac Failure Congestive: 8 people, 50.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 50.00%
Weight Increased: 8 people, 50.00%
Eyelid Ptosis (falling of the upper or lower eyelid): 7 people, 43.75%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 7 people, 43.75%

What are the existing conditions these people have? *

Pain: 8 people, 50.00%
Colitis (inflammation of colon): 7 people, 43.75%
Neoplasm Malignant (cancer tumour): 2 people, 12.50%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 12.50%
Sleep Disorder: 1 person, 6.25%
Sarcoma (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues): 1 person, 6.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.25%
Back Pain: 1 person, 6.25%
Asthma: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Sutent and have Psychiatric symptom?

- Check whether Psychiatric symptom is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sutent:

Sutent (44,554 reports)

Browse all side effects of Sutent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Psychiatric symptom:

Psychiatric symptom (639 drugs)

Browse all the conditions that are associated with Psychiatric symptom:

Psychiatric symptom (757 conditions)

Related publications that referenced our studies

Moftah NH, Kamel AM, Attia HM, El-Baz MZ, El–Moty HM, "Skin diseases in patients with primary psychiatric conditions: a hospital based study", Journal of epidemiology and global health, 2013 Sep .
Moftah NH, Kamel AM, Attia HM, El-Baz MZ, El–Moty HM, "Skin diseases in patients with primary psychiatric conditions: a hospital based study", Journal of epidemiology and global health, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on sunitinib malate (the active ingredients of Sutent) and Sutent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.